E

Echo Therapeutics

8 employees

Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.

Basic info

Industry

medical equipment manufacturing

Sectors

Medical Device
Biotechnology
non-invasive sensing technologies
Health Care
medical devices
Therapeutics
continuous glucose monitoring

Date founded

1989

Funding rounds raised

Total raised

$10M

from 1 investors over 1 rounds

E

Echo Therapeutics raised $10M on December 19, 2013

Investors: Platinum Management (NY) LLC

FAQ